Sunday, February 12, 2017

Dollar-a-dose, off-patent drug being marketed in the US for $89,000 as a muscular dystrophy treatment

Dollar-a-dose, off-patent drug being marketed in the US for $89,000 as a muscular dystrophy treatment
Out Shkreli-ing Shkreli. I didn't think it was possible to go that low, but apparently this is no bottom.

No comments:

Post a Comment